Western blot analysis of extracts from 293T cells, untreated (-) or treated with INK128 (100 nM, 1 hr; +), using Phospho-p70 S6 Kinase (Thr389) (D5U1O) Rabbit mAb #97596 (upper), or p70 S6 Kinase (49D7) Rabbit mAb #2708 (lower).Learn more about how we get our images
Chemical structure of INK128.Learn more about how we get our images
INK128 is supplied as a lyophilized powder. For a 15 mM stock, reconstitute 5 mg of powder in 1.07 ml of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.
Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.
Molecular Weight: 309.3 g/mol
Molecular Formula: C15H15N7O
Solubility: Soluble in DMSO at 25 mg/ml.
INK128, also known as MLN0128, is a second-generation active-site mTOR inhibitor (asTORi). Treating cells with INK128 leads to the dephosphorylation of mTOR downstream targets including p70 S6 kinase and 4E-BP1 (1,2). Research has proven that INK128 is an effective mTOR inhibitor because it targets both the mTORC1 and mTORC2 complexes at a high potency (Ki = 1.4nM) (1). Studies have shown that INK128 has anti-leukemic effects and can induce apoptosis at higher concentrations (3).
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.
To get local purchase information on this product, click here.